Cargando…

Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I

OBJECTIVE: Mucopolysaccharidosis I (MPS I) is a progressive, debilitating, and life-threatening genetic disease, which, owing to the nonspecific nature of the early symptoms, is often unrecognized and associated with significant diagnostic delays. To improve early recognition leading to early diagno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arn, Pamela, Bruce, Iain A., Wraith, James E., Travers, Helen, Fallet, Shari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361463/ https://www.ncbi.nlm.nih.gov/pubmed/25214650 http://dx.doi.org/10.1177/0003489414550154

Ejemplares similares

Anaesthesia and airway management in mucopolysaccharidosis
por: Walker, Robert, et al.
Publicado: (2012)

The natural history of MPS I: global perspectives from the MPS I Registry
por: Beck, Michael, et al.
Publicado: (2014)

Airway Abnormalities in Adult Mucopolysaccharidosis and Development of Salford Mucopolysaccharidosis Airway Score
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry
por: D’Aco, Kristin, et al.
Publicado: (2012)

The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
por: Moore, David, et al.
Publicado: (2008)

Neuropathology in Mouse Models of Mucopolysaccharidosis Type I, IIIA and IIIB
por: Wilkinson, Fiona L., et al.
Publicado: (2012)

Mucopolysaccharidosis Type I
por: Kubaski, Francyne, et al.
Publicado: (2020)

Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
por: Schulze-Frenking, G., et al.
Publicado: (2010)

Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
por: Pal, Abhijit Ricky, et al.
Publicado: (2018)

Assessment of Sleep in Children with Mucopolysaccharidosis Type III
por: Mahon, Louise Victoria, et al.
Publicado: (2014)

An investigation of the middle and late behavioural phenotypes of Mucopolysaccharidosis Type-III
por: Cross, Elaine M, et al.
Publicado: (2014)

Awake airway endoscopy in mucopolysaccharidosis: a case report
por: Fernandes, Sofia, et al.
Publicado: (2021)

Endoscopic and Image Analysis of the Airway in Patients with Mucopolysaccharidosis Type IVA
por: Lee, Yi-Hao, et al.
Publicado: (2023)

Heparan Sulfate Inhibits Hematopoietic Stem and Progenitor Cell Migration and Engraftment in Mucopolysaccharidosis I
por: Watson, H. Angharad, et al.
Publicado: (2014)

Mucopolysaccharidosis VI
por: Valayannopoulos, Vassili, et al.
Publicado: (2010)

Airway management in mucopolysaccharidosis: a retrospective case series review
por: Tümer, Murat, et al.
Publicado: (2021)

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey
por: Link, Bianca, et al.
Publicado: (2010)

Aortic Root Dilatation in Mucopolysaccharidosis I–VII
por: Bolourchi, Meena, et al.
Publicado: (2016)

Open issues in Mucopolysaccharidosis type I-Hurler
por: Parini, Rossella, et al.
Publicado: (2017)

Molecular Analysis of Vietnamese Patients with Mucopolysaccharidosis Type I
por: Can, Ngoc Thi Bich, et al.
Publicado: (2021)

Phenotypic expansion of ARSK ‐related mucopolysaccharidosis
por: Rustad, Cecilie F., et al.
Publicado: (2022)

Short stature as a presenting symptom of attenuated Mucopolysaccharidosis type I: case report and clinical insights
por: Martins, Ana Maria, et al.
Publicado: (2018)

Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease
por: Scarpa, Maurizio, et al.
Publicado: (2011)

Hyo-Mental Angle and Distance: An Important Adjunct in Airway Assessment of Adult Mucopolysaccharidosis
por: Gadepalli, Chaitanya, et al.
Publicado: (2021)

Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children
por: Soni-Jaiswal, A., et al.
Publicado: (2016)

Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
por: Lyons, Jeremiah A., et al.
Publicado: (2011)

α-L-iduronidase therapy for mucopolysaccharidosis type I
por: Tolar, Jakub, et al.
Publicado: (2008)

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
por: Giugliani, Roberto, et al.
Publicado: (2017)

Phenotype prediction for mucopolysaccharidosis type I by in silico analysis
por: Ou, Li, et al.
Publicado: (2017)

Cognitive Abilities of Dogs with Mucopolysaccharidosis I: Learning and Memory
por: Provoost, Lena, et al.
Publicado: (2020)

Mucopolysaccharidosis Type I in Mexico: Case-Based Review
por: Cantú-Reyna, Consuelo, et al.
Publicado: (2023)

Drosophila D-idua Reduction Mimics Mucopolysaccharidosis Type I Disease-Related Phenotypes
por: De Filippis, Concetta, et al.
Publicado: (2021)

Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement
por: Hampe, Christiane S., et al.
Publicado: (2021)

Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I
por: Lund, Troy C., et al.
Publicado: (2020)

Insights into Mucopolysaccharidosis I from the structure and action of α-L-Iduronidase
por: Bie, Haiying, et al.
Publicado: (2013)

Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test
por: Langford-Smith, Alex, et al.
Publicado: (2011)

Case Report: Cerebral Revascularization in a Child With Mucopolysaccharidosis Type I
por: Grant, Nathan, et al.
Publicado: (2021)

Clinical and Molecular Characterization of Patients with Mucopolysaccharidosis Type I in an Algerian Series
por: Tebani, Abdellah, et al.
Publicado: (2016)

Mutation analysis and clinical characterization of Iranian patients with mucopolysaccharidosis type I
por: Taghikhani, Mohammad, et al.
Publicado: (2019)

Improvement in time to treatment, but not time to diagnosis, in patients with mucopolysaccharidosis type I
por: Giugliani, Roberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hrfooag1bfgm8flrhgo4caph78